Free Trial

Spero Therapeutics (SPRO) SEC Filings & 10K Form

Spero Therapeutics logo
$0.65 -0.01 (-1.97%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.66 +0.01 (+1.39%)
As of 05/2/2025 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Spero Therapeutics SEC Filings

DateFilerForm TypeView
04/28/2025
4:08 PM
Spero Therapeutics (Filer)
Form ARS
04/28/2025
3:29 PM
Spero Therapeutics (Filer)
Form DEFA14A
03/28/2025
3:30 PM
GSK plc (Filed by)
Spero Therapeutics (Subject)
Form SCHEDULE 13D/A
03/27/2025
4:19 PM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
3:30 PM
Spero Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2025
4:11 PM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
8:04 PM
Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:52 PM
Rajavelu Esther (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:30 PM
Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:31 PM
Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:00 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:37 PM
Anson Funds Management LP (Filed by)
Spero Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:02 PM
Spero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
4:01 PM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
5:56 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
5:36 PM
Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:42 PM
Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:43 PM
Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
6:56 PM
Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SPRO) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners